this type of autoantibody occurred in 33 % of 100 cases with vitiligo , in 32.5 % of 40 cases with psoriasis , in 55.3 % of patients with malignant tumours and in 72.7 % of subjects with malignant melanoma .
C0006826
malignant tumours
C0025202
malignant